Report Detail

Other Global Cell therapy Processing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3749053
  • |
  • 16 September, 2019
  • |
  • Global
  • |
  • 136 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Cell therapy is the transplantation of human cells to replace or repair damaged tissue or cells. With new technologies and innovative products, many different types of cells can be used as part of a therapy or a treatment for a variety of diseases and conditions.

Scope of the Report:
The global Cell therapy Processing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell therapy Processing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cell therapy Processing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell therapy Processing market by product type and applications/end industries.

Market Segment by Companies, this report covers
Anthrogenesis Corp.
BioNTech
Cell Ideas
Epic Sciences
Roche
FuGENE
IBC Pharmaceuticals Inc.
Bluebird Bio Inc.
Immodulon-Therapeutics
Immunomedics Inc.
Juno Therapeutics Inc.
Medlmmune Inc.
NeoStem Oncology
Neurotech USA
Novartis
Persimmune Inc.
Pluristem Therapeutics
BioMed Valley Discoveries Inc.
Regeneron Pharmaceuticals Inc.
UCL Business PLC.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Products
Services
Software

Market Segment by Applications, can be divided into
Cardiovascular Disease
Bone Repair
Neurological Disorders
Skeletal Muscle RepairImmune Diseases


Table of Contents

    1 Cell therapy Processing Market Overview

    • 1.1 Product Overview and Scope of Cell therapy Processing
    • 1.2 Classification of Cell therapy Processing by Types
      • 1.2.1 Global Cell therapy Processing Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Cell therapy Processing Revenue Market Share by Types in 2018
      • 1.2.3 Products
      • 1.2.4 Services
      • 1.2.5 Software
    • 1.3 Global Cell therapy Processing Market by Application
      • 1.3.1 Global Cell therapy Processing Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Cardiovascular Disease
      • 1.3.3 Bone Repair
      • 1.3.4 Neurological Disorders
      • 1.3.5 Skeletal Muscle RepairImmune Diseases
    • 1.4 Global Cell therapy Processing Market by Regions
      • 1.4.1 Global Cell therapy Processing Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Cell therapy Processing Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Cell therapy Processing Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell therapy Processing Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Cell therapy Processing Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell therapy Processing Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Cell therapy Processing (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Anthrogenesis Corp.
      • 2.1.1 Business Overview
      • 2.1.2 Cell therapy Processing Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Anthrogenesis Corp. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 BioNTech
      • 2.2.1 Business Overview
      • 2.2.2 Cell therapy Processing Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 BioNTech Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Cell Ideas
      • 2.3.1 Business Overview
      • 2.3.2 Cell therapy Processing Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Cell Ideas Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Epic Sciences
      • 2.4.1 Business Overview
      • 2.4.2 Cell therapy Processing Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Epic Sciences Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Roche
      • 2.5.1 Business Overview
      • 2.5.2 Cell therapy Processing Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Roche Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 FuGENE
      • 2.6.1 Business Overview
      • 2.6.2 Cell therapy Processing Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 FuGENE Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 IBC Pharmaceuticals Inc.
      • 2.7.1 Business Overview
      • 2.7.2 Cell therapy Processing Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Bluebird Bio Inc.
      • 2.8.1 Business Overview
      • 2.8.2 Cell therapy Processing Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Bluebird Bio Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Immodulon-Therapeutics
      • 2.9.1 Business Overview
      • 2.9.2 Cell therapy Processing Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Immodulon-Therapeutics Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Immunomedics Inc.
      • 2.10.1 Business Overview
      • 2.10.2 Cell therapy Processing Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Immunomedics Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Juno Therapeutics Inc.
      • 2.11.1 Business Overview
      • 2.11.2 Cell therapy Processing Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Juno Therapeutics Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Medlmmune Inc.
      • 2.12.1 Business Overview
      • 2.12.2 Cell therapy Processing Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Medlmmune Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 NeoStem Oncology
      • 2.13.1 Business Overview
      • 2.13.2 Cell therapy Processing Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 NeoStem Oncology Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Neurotech USA
      • 2.14.1 Business Overview
      • 2.14.2 Cell therapy Processing Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Neurotech USA Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Novartis
      • 2.15.1 Business Overview
      • 2.15.2 Cell therapy Processing Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Novartis Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Persimmune Inc.
      • 2.16.1 Business Overview
      • 2.16.2 Cell therapy Processing Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Persimmune Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Pluristem Therapeutics
      • 2.17.1 Business Overview
      • 2.17.2 Cell therapy Processing Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Pluristem Therapeutics Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 BioMed Valley Discoveries Inc.
      • 2.18.1 Business Overview
      • 2.18.2 Cell therapy Processing Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Regeneron Pharmaceuticals Inc.
      • 2.19.1 Business Overview
      • 2.19.2 Cell therapy Processing Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 UCL Business PLC.
      • 2.20.1 Business Overview
      • 2.20.2 Cell therapy Processing Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 UCL Business PLC. Cell therapy Processing Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Cell therapy Processing Market Competition, by Players

    • 3.1 Global Cell therapy Processing Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Cell therapy Processing Players Market Share
      • 3.2.2 Top 10 Cell therapy Processing Players Market Share
    • 3.3 Market Competition Trend

    4 Global Cell therapy Processing Market Size by Regions

    • 4.1 Global Cell therapy Processing Revenue and Market Share by Regions
    • 4.2 North America Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 4.5 South America Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Cell therapy Processing Revenue and Growth Rate (2014-2019)

    5 North America Cell therapy Processing Revenue by Countries

    • 5.1 North America Cell therapy Processing Revenue by Countries (2014-2019)
    • 5.2 USA Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Cell therapy Processing Revenue and Growth Rate (2014-2019)

    6 Europe Cell therapy Processing Revenue by Countries

    • 6.1 Europe Cell therapy Processing Revenue by Countries (2014-2019)
    • 6.2 Germany Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 6.3 UK Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 6.4 France Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Cell therapy Processing Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Cell therapy Processing Revenue by Countries

    • 7.1 Asia-Pacific Cell therapy Processing Revenue by Countries (2014-2019)
    • 7.2 China Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 7.5 India Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Cell therapy Processing Revenue and Growth Rate (2014-2019)

    8 South America Cell therapy Processing Revenue by Countries

    • 8.1 South America Cell therapy Processing Revenue by Countries (2014-2019)
    • 8.2 Brazil Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Cell therapy Processing Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Cell therapy Processing by Countries

    • 9.1 Middle East and Africa Cell therapy Processing Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Cell therapy Processing Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Cell therapy Processing Revenue and Growth Rate (2014-2019)

    10 Global Cell therapy Processing Market Segment by Type

    • 10.1 Global Cell therapy Processing Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Cell therapy Processing Market Forecast by Type (2019-2024)
    • 10.3 Products Revenue Growth Rate (2014-2024)
    • 10.4 Services Revenue Growth Rate (2014-2024)
    • 10.5 Software Revenue Growth Rate (2014-2024)

    11 Global Cell therapy Processing Market Segment by Application

    • 11.1 Global Cell therapy Processing Revenue Market Share by Application (2014-2019)
    • 11.2 Cell therapy Processing Market Forecast by Application (2019-2024)
    • 11.3 Cardiovascular Disease Revenue Growth (2014-2019)
    • 11.4 Bone Repair Revenue Growth (2014-2019)
    • 11.5 Neurological Disorders Revenue Growth (2014-2019)
    • 11.6 Skeletal Muscle RepairImmune Diseases Revenue Growth (2014-2019)

    12 Global Cell therapy Processing Market Size Forecast (2019-2024)

    • 12.1 Global Cell therapy Processing Market Size Forecast (2019-2024)
    • 12.2 Global Cell therapy Processing Market Forecast by Regions (2019-2024)
    • 12.3 North America Cell therapy Processing Revenue Market Forecast (2019-2024)
    • 12.4 Europe Cell therapy Processing Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Cell therapy Processing Revenue Market Forecast (2019-2024)
    • 12.6 South America Cell therapy Processing Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Cell therapy Processing Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Cell therapy Processing. Industry analysis & Market Report on Cell therapy Processing is a syndicated market report, published as Global Cell therapy Processing Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Cell therapy Processing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,780.52
      4,170.78
      5,561.04
      3,232.92
      4,849.38
      6,465.84
      541,105.20
      811,657.80
      1,082,210.40
      290,510.40
      435,765.60
      581,020.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report